Clifford Neuman - Global Healthcare Secretary and Independent Director
GBCS Stock | USD 2.00 0.50 33.33% |
Director
Mr. Clifford L. Neuman, Esq., is a Director of the Company. He was Secretary of the Company. He was Independent Director of Global Healthcare REIT, Inc. Mr. Neuman was engaged as a principal in his own law firms for over 40 years, emphasizing corporate and securities law in the representation of companies in matters of corporate finance, mergers, acquisitions, reorganizations and public and private offerings. Mr. Neuman has served on the boards of directors of numerous public, private and nonprofit companies and was actively involved in the process of capital formation on behalf of his clients for many years. He is also the Managing Partner of Gemini Gaming, LLC, which owns and operates a gaming casino in Blackhawk, Colorado. He currently serves as Chairman of the Board of Medicine Horse Program, a nonprofit equine assisted psychotherapy facility in Boulder, a Director and CEO of Ratna Foundation, a nonprofit charitable foundation, and a member of the Governing Council of Shambhala Mountain Center, a nonprofit retreat center in Red Feather Lakes, Colorado since 2016.
Age | 68 |
Tenure | 8 years |
Phone | 303-449-2100 |
Web | https://www.gbcsreit.com |
Global Healthcare Management Efficiency
Global Healthcare's management efficiency ratios could be used to measure how well Global Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | DIRECTOR Age | ||
Alexander Hamilton | Barloworld Ltd ADR | 68 | |
Hester Hickey | Barloworld Ltd ADR | 62 | |
Oupa Shongwe | Barloworld Ltd ADR | 54 | |
Gavin Knight | Barloworld Ltd ADR | N/A | |
Vincent Foucart | SCOR PK | 39 | |
Peter Schmid | Barloworld Ltd ADR | 53 | |
Marguerite BerardAndrieu | SCOR PK | 40 | |
Steven Pfeiffer | Barloworld Ltd ADR | 63 | |
Alexander Landia | Barloworld Ltd ADR | 50 | |
Nomavuso Mnxasana | Barloworld Ltd ADR | 60 | |
Daniel Valot | SCOR PK | 70 | |
Wang Zhen | SCOR PK | 61 | |
Michele Aronvald | SCOR PK | 57 | |
Kory Sorenson | SCOR PK | 49 | |
Neo Dongwana | Barloworld Ltd ADR | 44 | |
Dominic Sewela | Barloworld Ltd ADR | 51 | |
Guylaine Saucier | SCOR PK | 68 | |
Bruno Pfister | SCOR PK | 59 | |
Peter Eckert | SCOR PK | 70 | |
Sango Ntsaluba | Barloworld Ltd ADR | 56 | |
Donald Wilson | Barloworld Ltd ADR | 59 |
Management Performance
Return On Equity | -0.6 | |||
Return On Asset | -2.0E-4 |
Global Healthcare REIT Leadership Team
Elected by the shareholders, the Global Healthcare's board of directors comprises two types of representatives: Global Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Global. The board's role is to monitor Global Healthcare's management team and ensure that shareholders' interests are well served. Global Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Global Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
Zvi Rhine, Director | ||
Lance Baller, Interim CEO, Interim Pres and Director | ||
John Downs, Director | ||
Josh Mandell, Director | ||
Christopher Barker, COO Pres | ||
Philip Scarborough, CFO and Principal Accounting Officer | ||
Clifford Neuman, Secretary and Independent Director | ||
Adam Desmond, Director | ||
Steven Bathgate, Secretary, Director | ||
Sarah Day, Marketing Therapy | ||
Jacob Taylor, Controller, Secretary | ||
Christine Lucus, CFO Sec | ||
Andrew Sink, Interim COO and Director |
Global Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Global Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.6 | |||
Return On Asset | -2.0E-4 | |||
Profit Margin | (0.05) % | |||
Operating Margin | (0.0004) % | |||
Current Valuation | 50.96 M | |||
Shares Outstanding | 3.07 M | |||
Shares Owned By Insiders | 24.97 % | |||
Price To Earning | 46.73 X | |||
Price To Book | 3.95 X | |||
Price To Sales | 0.39 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Global Healthcare in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Global Healthcare's short interest history, or implied volatility extrapolated from Global Healthcare options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Global Healthcare REIT. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Global Healthcare REIT information on this page should be used as a complementary analysis to other Global Healthcare's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Complementary Tools for Global Pink Sheet analysis
When running Global Healthcare's price analysis, check to measure Global Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Global Healthcare is operating at the current time. Most of Global Healthcare's value examination focuses on studying past and present price action to predict the probability of Global Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Global Healthcare's price. Additionally, you may evaluate how the addition of Global Healthcare to your portfolios can decrease your overall portfolio volatility.
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Global Correlations Find global opportunities by holding instruments from different markets | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |